{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:17:18Z","timestamp":1794953838179,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["15652222"],"award-info":[{"award-number":["15652222"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009028","name":"Japan Science and Technology Agency Research Institute of Science and Technology for Society","doi-asserted-by":"publisher","award":["20K08278"],"award-info":[{"award-number":["20K08278"]}],"id":[{"id":"10.13039\/501100009028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.117071","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:00:04Z","timestamp":1786039204000},"page":"117071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer"],"prefix":"10.1016","volume":"29","author":[{"given":"Makoto","family":"Sano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2379-7986","authenticated-orcid":false,"given":"Hideaki","family":"Ijichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Shimma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Masugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Ichimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Masamune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117071_bib1","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.117071_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","article-title":"Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions","volume":"25","author":"Hruban","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.isci.2026.117071_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191939","article-title":"KRAS: the Achilles\u2019 heel of pancreas cancer biology","volume":"135","author":"Drizyte-Miller","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117071_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117071_bib5","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1101\/gad.1158703","article-title":"Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma","volume":"17","author":"Aguirre","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.isci.2026.117071_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117071_bib7","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1073\/pnas.0601273103","article-title":"Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse","volume":"103","author":"Bardeesy","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.117071_bib8","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1101\/gad.1478706","article-title":"Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer","volume":"20","author":"Bardeesy","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.isci.2026.117071_bib9","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1101\/gad.1475506","article-title":"Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression","volume":"20","author":"Ijichi","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.isci.2026.117071_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2007.01.017","article-title":"Kras(G12D) and Smad4\/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas","volume":"11","author":"Izeradjene","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117071_bib11","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1172\/JCI42754","article-title":"Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma","volume":"121","author":"Ijichi","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117071_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41389-018-0117-8","article-title":"Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion\/migration and a shift of immune-inflammatory microenvironment","volume":"8","author":"Sano","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.isci.2026.117071_bib13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.1620164114","article-title":"Stromal cues regulate the pancreatic cancer epigenome and metabolome","volume":"114","author":"Sherman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.117071_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/cancers11101445","article-title":"NF-\u03baB Dependent Chemokine Signaling in Pancreatic Cancer","volume":"11","author":"Geismann","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.117071_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13402-026-01191-9","article-title":"The histone acylation network: emerging therapeutic targets for remodeling the epigenetic landscape in pancreatic ductal adenocarcinoma","volume":"49","author":"Kong","year":"2026","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.isci.2026.117071_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","article-title":"Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis","volume":"9","author":"Carrer","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.117071_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4161\/epi.4.6.9767","article-title":"Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation","volume":"4","author":"Madiraju","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.isci.2026.117071_bib18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1158\/2159-8290.CD-19-0297","article-title":"Oncogenic KRAS-driven metabolic reprogramming in pancreatic cancer cells utilizes cytokines from the tumor microenvironment","volume":"10","author":"Dey","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.117071_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","article-title":"Targeting pancreatic cancer metabolic dependencies through glutamine antagonism","volume":"5","author":"Encarnaci\u00f3n-Rosado","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2026.117071_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.isci.2026.117071_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117071_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117071_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bjsports-2016-096357","article-title":"Story behind meldonium-from pharmacology to performance enhancement: a narrative review","volume":"51","author":"Schobersberger","year":"2017","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.isci.2026.117071_bib24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1136\/gutjnl-2020-320608","article-title":"Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis\/thromboembolism","volume":"70","author":"Sano","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.117071_bib25","doi-asserted-by":"crossref","DOI":"10.12775\/QS.2024.35.56339","article-title":"Meldonium \u2013 A high potential drug. Literature review","volume":"35","author":"Ochwat","year":"2024","journal-title":"Qual. Sport"},{"key":"10.1016\/j.isci.2026.117071_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/ijms23010045","article-title":"Protective effects of meldonium in experimental models of cardiovascular complications with a potential application in COVID-19","volume":"23","author":"Vilskersts","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117071_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/biomedicines8080270","article-title":"Mitochondrial metabolism in PDAC: From better knowledge to new targeting strategies","volume":"8","author":"Reyes-Castellanos","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.117071_bib28","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.3390\/cancers14184351","article-title":"Targeting the metabolic rewiring in pancreatic cancer and its tumor microenvironment","volume":"14","author":"Yamamoto","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2026.117071_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3892\/ijo.2023.5499","article-title":"RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer","volume":"62","author":"Ono","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.isci.2026.117071_bib30","article-title":"EP300 promotes ferroptosis via HSPA5 acetylation in pancreatic cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117071_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tibs.2017.11.004","article-title":"Spatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation","volume":"43","author":"Sivanand","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.isci.2026.117071_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.560487","article-title":"Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy","volume":"10","author":"Wu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117071_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188676","article-title":"Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer","volume":"1877","author":"Xiang","year":"2022","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117071_bib34","doi-asserted-by":"crossref","first-page":"19074","DOI":"10.18632\/oncotarget.13572","article-title":"Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts","volume":"8","author":"Nguyen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.117071_bib35","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.7150\/thno.73223","article-title":"Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.117071_bib36","doi-asserted-by":"crossref","DOI":"10.4155\/fsoa-2018-0115","article-title":"Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy","volume":"5","author":"Alqahtani","year":"2019","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.isci.2026.117071_bib56","doi-asserted-by":"crossref","first-page":"61469","DOI":"10.18632\/oncotarget.11129","article-title":"Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer","volume":"7","author":"Yamamoto","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.117071_bib38","first-page":"40","article-title":"BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models","volume":"7","author":"Miller","year":"2024","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.isci.2026.117071_bib37","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1002\/jcp.27602","article-title":"Meldonium improves Huntington's disease mitochondrial dysfunction by restoring peroxisome proliferator-activated receptor gamma coactivator 1alpha expression","volume":"234","author":"Di Cristo","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.isci.2026.117071_bib39","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/1078-0432.CCR-18-2380","article-title":"L-Carnitine-mediated tumor cell protection and poor patient survival associated with OCTN2 overexpression in glioblastoma multiforme","volume":"25","author":"Fink","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117071_bib40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tem.2021.03.007","article-title":"Cancer-mediated muscle cachexia: Etiology and clinical management","volume":"32","author":"Siff","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.117071_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia","volume":"15","author":"Mantovani","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.isci.2026.117071_bib42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2891-11-52","article-title":"L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial","volume":"11","author":"Kraft","year":"2012","journal-title":"Nutr. J."},{"key":"10.1016\/j.isci.2026.117071_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/646171","article-title":"Potential therapeutic role of L-carnitine in skeletal muscle oxidative stress and atrophy conditions","volume":"2015","author":"Montesano","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2026.117071_bib44","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3390\/ijms23042395","article-title":"The Effects of a meldonium pre-treatment on the course of the LPS-induced sepsis in rats","volume":"23","author":"\u0110ura\u0161evi\u0107","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117071_bib45","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1097\/j.pain.0000000000001997","article-title":"Duloxetine improves cancer-associated pain in a mouse model of pancreatic cancer through stimulation of noradrenaline pathway and its antitumor effects","volume":"161","author":"Kajiwara","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.isci.2026.117071_bib46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.phrs.2016.01.019","article-title":"Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity","volume":"113","author":"Dambrova","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.117071_bib55","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3109\/14756360902829527","article-title":"Inhibition of carnitine acetyltransferase by mildronate, a regulator of energy metabolism","volume":"24","author":"Jaudzems","year":"2009","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.isci.2026.117071_bib47","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.tranon.2019.08.010","article-title":"Indirubin 3'-oxime inhibits migration, invasion, and metastasis in vivo in mice bearing spontaneously occurring pancreatic cancer via blocking the RAF\/ERK, AKT, and SAPK\/JNK pathways","volume":"12","author":"Ichimaru","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.isci.2026.117071_bib48","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/gut.2008.154401","article-title":"Fibrinogen induces cytokine and collagen production in pancreatic stellate cells","volume":"58","author":"Masamune","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.117071_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","article-title":"Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles","volume":"6","author":"Sugimoto","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/j.isci.2026.117071_bib50","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1158\/0008-5472.CAN-08-4806","article-title":"Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry","volume":"69","author":"Hirayama","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117071_bib51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/pr034020m","article-title":"Quantitative metabolome analysis using capillary electrophoresis mass spectrometry","volume":"2","author":"Soga","year":"2003","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.isci.2026.117071_bib52","doi-asserted-by":"crossref","first-page":"16768","DOI":"10.1074\/jbc.M601876200","article-title":"Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption","volume":"281","author":"Soga","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117071_bib53","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1021\/ac900675k","article-title":"Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry","volume":"81","author":"Soga","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.isci.2026.117071_bib54","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.metabol.2013.07.002","article-title":"Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis","volume":"62","author":"Saito","year":"2013","journal-title":"Metabolism"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226024491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226024491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:42:31Z","timestamp":1794951751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226024491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226024491"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117071","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117071"}}